Treatment strategy for patients with end-stage hip disease and ipsilateral intertrochanteric fracture: 1-stage or 2-stage total hip arthroplasty?

BACKGROUND: The optimal treatment strategy for patients with ipsilateral intertrochanteric fracture and pre-existing end-stage hip disease requiring total hip arthroplasty (THA) remains unclear. PURPOSE: This study aimed to compare perioperative surrogate markers, clinical outcomes, and radiological outcomes between 1-stage and 2-stage THA. METHODS: This retrospective single-center cohort study reviewed 75 patients, including 42 who underwent 1-stage THA shortly after intertrochanteric fracture onset and 33 who underwent initial internal fixation followed by secondary THA after fracture union. Perioperative surrogate markers, clinical outcomes, radiological outcomes, and complications were compared between the 2 groups. RESULTS: No femoral stem revision, radiographic loosening, or reoperation-related mortality occurred in either group during follow-up. During the arthroplasty procedure, 1-stage THA required longer operative time (120 [53] minutes vs. 90 [25] minutes), greater intraoperative blood loss (400 [200] ml vs. 300 [200] ml), and greater transfusion requirement (transfusion rate: 42.9% vs. 21.2%; transfusion volume: 500 [400] ml vs. 400 [200] ml). Because femoral canal preparation and stem insertion during 1-stage THA occupied the proximal femoral space required for fragment reduction, this group had poorer fracture reduction quality (optimal reduction: 14.3% vs. 42.4%) and inferior early postoperative function, as reflected by lower Harris Hip Scores and higher WOMAC scores. However, clinical outcomes did not differ between the 2 groups after 1 year. Intraoperative periprosthetic femoral fracture and postoperative stem malalignment were more frequently observed in the 2-stage THA group. CONCLUSIONS: 1-stage THA enables fracture management and hip reconstruction in a single operation but may involve longer operative time, greater blood loss, and higher transfusion requirements during the arthroplasty procedure, as well as poorer early outcomes. 2-stage THA offers a more elective setting for arthroplasty after fracture union but requires an additional operation and carries specific risks during secondary THA, including intraoperative periprosthetic femoral fracture and femoral stem malalignment.

Authors

Institutions

Publication Details

Journal
Hip International
Published
2026-11-18
DOI
https://doi.org/10.1177/11207000261488878
Primary Topic
Orthopaedic implants and arthroplasty
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Treatment strategy for patients with end-stage hip disease and ipsilateral intertrochanteric fracture: 1-stage or 2-stage total hip arthroplasty?

Binquan Zhang, Zhaolong Wang, Huijie Li, Yifan Niu et al.
2 links
Hip International
Orthopaedic implants and arthroplasty
article

Treatment strategy for patients with end-stage hip disease and ipsilateral intertrochanteric fracture: 1-stage or 2-stage total hip arthroplasty?

Binquan Zhang, Zhaolong Wang, Huijie Li, Yifan Niu, Sikai Liu, Bo Liu
article en

Abstract

BACKGROUND: The optimal treatment strategy for patients with ipsilateral intertrochanteric fracture and pre-existing end-stage hip disease requiring total hip arthroplasty (THA) remains unclear. PURPOSE: This study aimed to compare perioperative surrogate markers, clinical outcomes, and radiological outcomes between 1-stage and 2-stage THA. METHODS: This retrospective single-center cohort study reviewed 75 patients, including 42 who underwent 1-stage THA shortly after intertrochanteric fracture onset and 33 who underwent initial internal fixation followed by secondary THA after fracture union. Perioperative surrogate markers, clinical outcomes, radiological outcomes, and complications were compared between the 2 groups. RESULTS: No femoral stem revision, radiographic loosening, or reoperation-related mortality occurred in either group during follow-up. During the arthroplasty procedure, 1-stage THA required longer operative time (120 [53] minutes vs. 90 [25] minutes), greater intraoperative blood loss (400 [200] ml vs. 300 [200] ml), and greater transfusion requirement (transfusion rate: 42.9% vs. 21.2%; transfusion volume: 500 [400] ml vs. 400 [200] ml). Because femoral canal preparation and stem insertion during 1-stage THA occupied the proximal femoral space required for fragment reduction, this group had poorer fracture reduction quality (optimal reduction: 14.3% vs. 42.4%) and inferior early postoperative function, as reflected by lower Harris Hip Scores and higher WOMAC scores. However, clinical outcomes did not differ between the 2 groups after 1 year. Intraoperative periprosthetic femoral fracture and postoperative stem malalignment were more frequently observed in the 2-stage THA group. CONCLUSIONS: 1-stage THA enables fracture management and hip reconstruction in a single operation but may involve longer operative time, greater blood loss, and higher transfusion requirements during the arthroplasty procedure, as well as poorer early outcomes. 2-stage THA offers a more elective setting for arthroplasty after fracture union but requires an additional operation and carries specific risks during secondary THA, including intraoperative periprosthetic femoral fracture and femoral stem malalignment.

Hip International
Third Hospital of Hebei Medical University (CN)
Good health and well-being
Orthopaedic implants and arthroplasty
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon